Restoring Balance: What the FDA's Peptide Announcement Could Mean for Patient Access and Safety Empower Pharmacy BPC 157 FDA Approval Status 2026: RFK Jr, Advisory Committee & Reclassification FDA Removes Key Peptides from Category 2: What This Means for You FDA Peptide Reclassification 2026: What Researchers Want FDA to Remove 12 Popular Peptides from the Category 2 Do Not Compound List Frier Levitt FDA Peptide Update 2026: Removal from Do Not Compound List and What It Means for Pharmacies This is one of the biggest peptide regulatory updates in years, and it's just the beginning. The FDA has officially initiated the first step to reverse its 2023 stance, removing 12 peptides